MX2020001058A - Marcadores de fusión para expresión de proteínas recombinantes. - Google Patents
Marcadores de fusión para expresión de proteínas recombinantes.Info
- Publication number
- MX2020001058A MX2020001058A MX2020001058A MX2020001058A MX2020001058A MX 2020001058 A MX2020001058 A MX 2020001058A MX 2020001058 A MX2020001058 A MX 2020001058A MX 2020001058 A MX2020001058 A MX 2020001058A MX 2020001058 A MX2020001058 A MX 2020001058A
- Authority
- MX
- Mexico
- Prior art keywords
- protein
- fusion
- protein expression
- recombinant protein
- target protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762538505P | 2017-07-28 | 2017-07-28 | |
| PCT/US2018/044156 WO2019023616A1 (en) | 2017-07-28 | 2018-07-27 | FUSION TAGS FOR EXPRESSING RECOMBINANT PROTEINS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020001058A true MX2020001058A (es) | 2020-08-06 |
Family
ID=63312460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020001058A MX2020001058A (es) | 2017-07-28 | 2018-07-27 | Marcadores de fusión para expresión de proteínas recombinantes. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12473340B2 (OSRAM) |
| EP (1) | EP3658574A1 (OSRAM) |
| JP (1) | JP2020529221A (OSRAM) |
| KR (1) | KR20200037819A (OSRAM) |
| CN (1) | CN111132996A (OSRAM) |
| AU (1) | AU2018307960B2 (OSRAM) |
| CA (1) | CA3071419A1 (OSRAM) |
| MX (1) | MX2020001058A (OSRAM) |
| SG (1) | SG11202000775SA (OSRAM) |
| WO (1) | WO2019023616A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020529221A (ja) | 2017-07-28 | 2020-10-08 | ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ | 組み換えタンパク質発現のための融合タグ |
| EP3983424A1 (en) * | 2019-06-14 | 2022-04-20 | Mytide Therapeutics, Inc. | A manufacturing process for peptide and protein production |
| WO2022094146A1 (en) | 2020-10-28 | 2022-05-05 | The Trustees Of Princeton University | Methods of converting precursor proteins to mature proteins using kex2 proteases |
| EP4277917A4 (en) * | 2021-01-14 | 2024-06-19 | Biocatalyst LLC | Compositions and methods for peptide production |
| CN113388009B (zh) * | 2021-05-18 | 2022-07-19 | 中国科学院福建物质结构研究所 | 一种标签蛋白及其编码基因、重组载体与应用 |
| KR102868986B1 (ko) * | 2022-09-27 | 2025-10-15 | 크리포 주식회사 | 주요 아미노산이 전하성 및 소수성 아미노산으로 구성된 분산된 His-태그 기반 펩타이드 태그를 포함하여 자가 조립체를 형성하는 융합 단백질 및 이를 이용하여 재조합 단백질을 정제하는 방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2705895A (en) | 1994-06-30 | 1996-01-25 | Novo Nordisk Biotech, Inc. | Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein |
| ES2425413T3 (es) | 2006-11-22 | 2013-10-15 | Novo Nordisk A/S | Método para preparar carboxipeptidasa activada |
| EP2831262B1 (en) | 2012-03-29 | 2018-02-14 | Biocon Limited | Secretion of functional insulin glargine directly into the culture medium through over expression of kex2p intracellularly |
| CN103031328B (zh) | 2012-11-22 | 2015-08-05 | 江南大学 | 利用一种融合标签提高外源蛋白质的表达量 |
| EP2970511B1 (en) | 2013-03-14 | 2020-09-30 | Indiana University Research and Technology Corporation | Insulin-incretin conjugates |
| US10000544B2 (en) | 2013-07-31 | 2018-06-19 | Biogenomics Limited | Process for production of insulin and insulin analogues |
| US10202607B2 (en) * | 2015-10-13 | 2019-02-12 | The Research Foundation For The State University Of New York | Cleavable fusion tag for protein overexpression and purification |
| JP2020529221A (ja) | 2017-07-28 | 2020-10-08 | ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ | 組み換えタンパク質発現のための融合タグ |
-
2018
- 2018-07-27 JP JP2020527858A patent/JP2020529221A/ja active Pending
- 2018-07-27 MX MX2020001058A patent/MX2020001058A/es unknown
- 2018-07-27 EP EP18759004.7A patent/EP3658574A1/en not_active Withdrawn
- 2018-07-27 KR KR1020207005772A patent/KR20200037819A/ko not_active Withdrawn
- 2018-07-27 US US16/633,991 patent/US12473340B2/en active Active
- 2018-07-27 CN CN201880062847.9A patent/CN111132996A/zh active Pending
- 2018-07-27 AU AU2018307960A patent/AU2018307960B2/en not_active Expired - Fee Related
- 2018-07-27 SG SG11202000775SA patent/SG11202000775SA/en unknown
- 2018-07-27 CA CA3071419A patent/CA3071419A1/en active Pending
- 2018-07-27 WO PCT/US2018/044156 patent/WO2019023616A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| SG11202000775SA (en) | 2020-02-27 |
| US12473340B2 (en) | 2025-11-18 |
| EP3658574A1 (en) | 2020-06-03 |
| US20200216512A1 (en) | 2020-07-09 |
| AU2018307960B2 (en) | 2023-03-23 |
| WO2019023616A1 (en) | 2019-01-31 |
| AU2018307960A1 (en) | 2020-02-27 |
| KR20200037819A (ko) | 2020-04-09 |
| JP2020529221A (ja) | 2020-10-08 |
| CN111132996A (zh) | 2020-05-08 |
| CA3071419A1 (en) | 2019-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020001058A (es) | Marcadores de fusión para expresión de proteínas recombinantes. | |
| MX2020013977A (es) | Proteínas quiméricas transmembrana y usos de las mismas. | |
| MX2020004149A (es) | Variantes de desoxirribonucleasa (dnasa). | |
| MX2019003674A (es) | Enzimas modificadoras de ácido nucleico guiadas por arn y métodos de uso de estas. | |
| MX2020004578A (es) | Composiciones de casz y metodos de uso. | |
| SA523441205B1 (ar) | التحرير المتعدد للجينوم | |
| CL2017002820A1 (es) | Variantes de alfa-amilasa y polinucleótidos que codifican las mismas | |
| MX389703B (es) | Anticuerpos anti-c1s humanizados y metodos para usarlos. | |
| MX2017003847A (es) | Proteinas biespecificas activables por proteasas. | |
| ECSP19011185A (es) | Proteínas de unión de tipo anticuerpo biespecíficas que se unen específicamente a CD3 y CD123 | |
| MX2015009594A (es) | Construcciones de anticuerpos para cdh19 y cd3. | |
| MX2017016688A (es) | Nuevas enzimas y sistemas crispr. | |
| EP3950941A3 (en) | Dnase polypeptide variants | |
| MX2017007826A (es) | Proteina de fusion que conprende tres dominios de union a 5t4 y cd3. | |
| MX2018011425A (es) | Construcciones de anticuerpos de adn y método para utilizarlas. | |
| MX388739B (es) | Casetes optimizados de expresión del gen humano del factor viii de coagulación y su uso. | |
| EA201690529A1 (ru) | Способы модификации клетки-хозяина | |
| MX2022016002A (es) | Construcciones de anticuerpos de adn y metodo para utilizarlas. | |
| MX421208B (es) | Antigenos prostaticos de consenso, molecula de acido nucleico que los codifica y vacuna y usos que los comprenden. | |
| MX2024009272A (es) | Constructos de anticuerpos de acidos nucleicos optimizados. | |
| BR112017020561A2 (pt) | transaminase mutante, proteína, ácido nucleico, célula hospedeira, método de produção de amina e uso de transaminase mutante | |
| PE20170941A1 (es) | Genes de tolerancia a herbicidas y metodos para usar los mismos | |
| CO2020005371A2 (es) | Anticuerpos anti-apoc3 y métodos de uso de estos | |
| ECSP17075380A (es) | Fusiones de variante iii del receptor de factor de crecimiento epidérmico-mesotelina y métodos para usar los mismos | |
| AR088647A1 (es) | Metodo para reducir el estres abiotico en la planta |